Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Laura Checkley, Scott Steiger & Kelly R. Knight. (2022) “I wanted something that was more flexible”: A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program. Substance Abuse 43:1, pages 767-773.
Read now
Read now
Sathya Prakash & Yatan Balhara. (2016) Perceptions Related to Pharmacological Treatment of Opioid Dependence Among Individuals Seeking Treatment at a Tertiary Care Center in Northern India: A Descriptive Study. Substance Use & Misuse 51:7, pages 861-869.
Read now
Read now
Duncan R. Hill, Stephen Conroy, Afreen Afzal, Debbie Lang, Siobhan Steele & Derna Campbell. (2015) A comparison of methadone and buprenorphine–naloxone as opioid substitution therapy: the patient perspective in NHS Lanarkshire. Journal of Substance Use 20:3, pages 168-177.
Read now
Read now
Adrian Octavian Abagiu, Zrinka Cavar, Pinhas Dannon, Philip George, Boguslaw Habrat, Zubeida Mahomedy, Petr Popov, Riza Sarasvita, Diah Setia Utami & Andrej Kastelic. (2014) Outcomes from the International Survey Informing Greater Insights in Opioid Dependence Treatment (INSIGHT) project. Drugs: Education, Prevention and Policy 21:6, pages 440-450.
Read now
Read now
Mats Ekendahl. (2011) The limits of legitimacy: Service providers’ views on maintenance treatment in Sweden. Addiction Research & Theory 19:5, pages 427-437.
Read now
Read now
G. R. Tanner, N. Bordon, S. Conroy & D. Best. (2011) Comparing methadone and Suboxone in applied treatment settings: the experiences of maintenance patients in Lanarkshire. Journal of Substance Use 16:3, pages 171-178.
Read now
Read now
Articles from other publishers (7)
Natasha Yvonne Hall, Long Le, Julie Abimanyi-Ochom & Cathy Mihalopoulos. (2023) Measuring the importance of different barriers to opioid agonist treatment using best-worst scaling in an Australian setting. Health Policy 138, pages 104939.
Crossref
Crossref
Natasha Yvonne Hall, Long Le, Ishani Majmudar & Cathrine Mihalopoulos. (2021) Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence 221, pages 108651.
Crossref
Crossref
Dharushana Muthulingam, Lynn M. Madden & Frederick L. Altice. 2021. The Opioid Epidemic and Infectious Diseases. The Opioid Epidemic and Infectious Diseases
161
187
.
Paul S. Haber, Mahmoud Elsayed, David Espinoza, Nicholas Lintzeris, Anne-Sophie Veillard & Richard Hallinan. (2017) Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment. Drug and Alcohol Dependence 181, pages 132-139.
Crossref
Crossref
Paula Alves & Adam Winstock. (2018) Patients' knowledge about treatment for opiate dependence. The Psychiatrist 35:12, pages 448-453.
Crossref
Crossref
Hayley Pinto, Vivienne Maskrey, Louise Swift, Daphne Rumball, Ajay Wagle & Richard Holland. (2010) The SUMMIT Trial:. Journal of Substance Abuse Treatment 39:4, pages 340-352.
Crossref
Crossref
Adam R. Winstock, Nicholas Lintzeris & Toby Lea. (2009) Why do patients report transferring between methadone and buprenorphine?. Drug and Alcohol Review 28:6, pages 686-687.
Crossref
Crossref